Ever since its inception, acrodermatitis continua of Hallopeau, has been recognized as an uncommon clinical entity which has been sparingly reported from across the globe. The attempt to have cumulative information on prevalent nomenclature, definition, reminiscences, and clinical overtures has brought differential diagnosis and diagnosis in sharp focus, the highlights of which are outlined. Hence, it was considered important to review the evolution of treatment options available thus far including use of biologics.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1365-4632.2011.04993.x | DOI Listing |
J Dermatol
January 2025
Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
J Eur Acad Dermatol Venereol
December 2024
Dermatology Hospital of Southern Medical University, Guangzhou, China.
Dermatol Pract Concept
October 2024
IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola, Dermatology Unit.
J Dermatolog Treat
December 2024
Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Background: Acrodermatitis continua of Hallopeau (ACH) is a rare pustular psoriasis variant predominantly affects the distal phalanges of the fingers and toes. However, data on aggravating factors and treatment outcomes is limited.
Objective: This study aims to analyze the aggravating factors and treatment outcomes of ACH in a three-tertiary-hospital in South China.
Australas J Dermatol
December 2024
Zhejiang Provincial Key Laboratory of Traditional Chinese Medicine Cultivation for Arthritis Diagnosis and Treatment, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!